Robert Dufour
Impact in
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
-
- Lipid metabolism and disorders
Papers in
- Surgery 54
- Lipoproteins and Cardiovascular Health 53
- Cholesterol and Lipid Metabolism 4
-
- Lipid metabolism and disorders 14
- Co-authors
- Daniel Gaudet (14 shared papers)Alexis Wilfrid Baass (23 shared papers)Evan A. Stein (7 shared papers)Traci A. Turner (2 shared papers)Robert C. Pordy (5 shared papers)John J.P. Kastelein (2 shared papers)Martine Paquette (13 shared papers)Jean Bergeron (10 shared papers)
- Journals
- Journal of clinical lipidology (18 papers)Canadian Journal of Cardiology (10 papers)Atherosclerosis (6 papers)The Lancet (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Robert Dufour
75 papers receiving 5.9k citations
Robert Dufour's Hit Papers
Peers
Comparison fields: 5 of 104
- Surgery 4.1k
- Cardiology and Cardiovascular Medicine 818
- Biochemistry 122
- Endocrinology, Diabetes and Metabolism 237
- Pharmacology 96
Countries citing papers authored by Robert Dufour
This map shows the geographic impact of Robert Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dufour more than expected).
Fields of papers citing papers by Robert Dufour
This network shows the impact of papers produced by Robert Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dufour. The network helps show where Robert Dufour may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Dufour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol Hit paper breakdown → | 2017 | 820 |
| 2 | PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2014 | 644 |
| 3 | 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations Hit paper breakdown → | 2009 | 622 |
| 4 | 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2013 | 619 |
| 5 | Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial Hit paper breakdown → | 2012 | 501 |
| 6 | ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia Hit paper breakdown → | 2015 | 479 |
| 7 | 2012 | 254 | |
| 8 | Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 193 |
| 9 | 2018 | 177 | |
| 10 | 2017 | 131 | |
| 11 | 1993 | 122 | |
| 12 | 2017 | 120 | |
| 13 | 2017 | 96 | |
| 14 | 2014 | 89 | |
| 15 | 2016 | 72 | |
| 16 | 2018 | 72 | |
| 17 | 2014 | 65 | |
| 18 | 2017 | 57 | |
| 19 | HMG-CoA reductase inhibitors: a look back and a look ahead. | 1992 | 56 |
| 20 | 2014 | 55 |
About Robert Dufour
Robert Dufour is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Physiology and Genetics, having authored 77 papers that have together received 6.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (53 papers), Lipid metabolism and disorders (14 papers), Cholesterol and Lipid Metabolism (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Alzheimer's disease research and treatments (3 papers), Health Promotion and Cardiovascular Prevention (3 papers), Genetic Associations and Epidemiology (3 papers) and Dementia and Cognitive Impairment Research (2 papers). The work is most often cited by research in Surgery (4.1k citations), Cardiology and Cardiovascular Medicine (818 citations), Biochemistry (122 citations), Endocrinology, Diabetes and Metabolism (237 citations) and Pharmacology (96 citations). Robert Dufour has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Daniel Gaudet, Alexis Wilfrid Baass, Evan A. Stein, Traci A. Turner, Robert C. Pordy, John J.P. Kastelein, Martine Paquette, Jean Bergeron, G. Kees Hovingh and Gisle Langslet. Their work appears in journals such as Journal of clinical lipidology, Canadian Journal of Cardiology, Atherosclerosis, The Lancet and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.